Weight-loss drugs could become a test case for AI
Briefly

Some companies are exploring the potential of combining artificial intelligence with weight-loss drugs such as GLP-1s for personalized care, driven by high demand, costs, and diverse applications.
AI technologies like Verily's Lightpath and companies like Dandelion Health and Allurion Technologies are leveraging AI to enhance insights, personalize care, and expand weight-loss coaching services in the healthcare industry.
Read at Axios
[
|
]